TY - JOUR A2 - Kuhnel, F. A2 - Ganesan, T. S. AU - López-Basave, Horacio N. AU - Morales-Vásquez, Flavia AU - Ruiz Molina, J. M. AU - González-Enciso, Aaron AU - Ñamendys-Silva, Silvio A. AU - Medina Castro, Juan M. AU - Montalvo-Esquivel, Gonzalo AU - Herrera-Gómez, Angel AU - De la Garza Salazar, Jaime G. PY - 2011 DA - 2011/08/03 TI - Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico SP - 526384 VL - 2011 AB - Peritoneal carcinomatosis (PC) is generally considered a lethal disease, with a poor prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a new approach for peritoneal surface disease. This study investigated the early experience with this combined modality treatment at a single institute. From January 2007 to March 2010, 24 patients were treated After aggressive CS, with HIPEC (cisplatin 25 mg/m2/L and mitomycin C 3.3 mg/m2/L was administered for 90-minutes at 40.5° C). These data suggest that aggressive CRS with HIPEC for the treatment of PC may result in low mortality and acceptable morbidity. Rigorous patient selection, appropriate and prudent operative procedures were associated with encouraging results in our experience. SN - null UR - https://doi.org/10.5402/2011/526384 DO - 10.5402/2011/526384 JF - ISRN Oncology PB - International Scholarly Research Network KW - ER -